Direct molecular analysis of FMR-1 gene mutation in patients with fragile Xq syndrome and their families;Análisis molecular directo de mutaciones en el gen FMR-1 en pacientes con Síndrome de Xq frágil y sus familias

Revista Medica de Chile

Volumn 126, Issue 12, 1998, Pages 1435-1446

  Alliende, M Angélica R ^a   Urzúa, Blanca O ^a   Valiente, Alf G ^a   Cortés, Fanny M ^a   Curotto, Bianca L ^a   Rojas, Cecilia B ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Cytogenetics; FMR 1 gene; Fragile X mutation detection; Fragile X syndrome; Mental retardation

Indexed keywords

FMR1 PROTEIN, HUMAN; FRAGILE X MENTAL RETARDATION PROTEIN; NERVE PROTEIN; RNA BINDING PROTEIN;

ARTICLE; FEMALE; FRAGILE X SYNDROME; GENETICS; HUMAN; MALE; MUTATION; PEDIGREE; X CHROMOSOME;

FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MALE; MUTATION; NERVE TISSUE PROTEINS; PEDIGREE; RNA-BINDING PROTEINS; X CHROMOSOME;

EID: 0032248495     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. SOUTHERN E. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-17.
2. MORTON J, BUNDEY S, WEBB T, MACDONALD F, RINDL PM, BULLOCK S. Fragile X syndrome is less common than previously estimated. J Med Genet 1997; 34: 1-5.
3. SUTHERLAND GR. Heritable fragile sites on human chromosomes. III. Detection of fra (X) (q 27) in males with X-linked mental retardation and their female relatives. Am J Hum Genet 1979; 53: 22-7.
4. MINGRONI-NETO R. A síndrome do cromossomo X frágil. Soc. Bras. Genét. Série Monografias 1995; 2: 47-109.
5. EBERHART D, MALTER H, FENG, Y, WARREN S. The fragile X mental retardation protein is a ribonucleoprotein containing nuclear localization and nuclear export signals. Hum Mol Genet 1996; 5: 1083-91.
6. OBERLÉ I, ROSSEAU F, HEITZ D, KRETZ C, DEVYS D, HANAUER A ET AL. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991; 252: 1097-102.
7. VERKERK AJMH, PIEKETTI M, SUTCLIFFE JS, FU Y-H, KUHL DPA, PIZZUTI A ET AL. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991; 65: 905-14.
8. YU S, PRITCHARD E, KREMER E, LYNCH M, NANCARROW J, BAKER E. Fragile X genotypt characterized by an unstable region of DNA. Science 1991; 252: 1179-81.
9. MINGRONI-NETTO R, HADDAD L, VIANNA-MORGANTE A. The Number of Repeats of the FMR1 Locus in Premutated and Fully Mutated Heterozygotes and Their Offspring: Implications for the Origin of Mosaicism Am J Med Genet 1996; 64: 270-3.
10. ZHONG N, JU W, PIETROFESA J, WANG D, DOBKIN C, BKOWN T. Fragile X "Gray Zone" Alleles: AGG Paterns, Expansion Risks, and Associated Haplotypes. Am J Med Genet 1996; 6-1: 261-5.
11. JARA L, ASPILLAGA M, AVENDAŃO I, OBREQUE V, BLANCO R, VALENZUELA CY. Distribution of (CGG)n and FMR-1 Associated Microsatellites Alleles in a Normal Chilean Population. Am J Med Genet 1998; 75: 277-82.
12. ROSSEAU F, HEITZ D, BIANCALANA V, BIUMENFELD S, KRETZ C, BOUÉ J ET AL. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 1991; 325: 1673-81.
13. FU YH, KUHL DP, PIZZUTI A, PIERETTI M, SUTCLIFFE JS, RICHARDS S ET AL. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991; 67: 1047-58.
14. VERHEIJ C, BAKKER CE, DE GRAAFF E, WILLEMSEN R, WILLIAMS PJ, MEIJER N ET AL. Characterization and localization of the FMR1 gene product associated with fragile X syndrome. Nature 1993; 363: 722-4.
15. TURNER G, WEBB T, WAKES S, ROBINSON S. Prevalence of fragile X syndrome. Am J Med Genet 1996; 64: 196-7.
16. YAMAUCHI M, NAGATA S, SEKI N, TOYAMA Y, HAKADA N, NUKAWA N ET AL. Prenatal diagnosis of fragile X syndrome by detection of the dynamic mutation due to an unstable DNA sequence. Clin Genet 1993; 44: 169-72.
17. ROUSSEAU F, HEITZ D, BIANCALANA V, OBERLÉ I, MANDEL JL. On some technical aspects of direct DNA diagnosis of the fragile X syndrome. Am J Med Genet 1992; 43: 197-207.
18. MURRAY J, CUCKLE H, TAYLOR G, HEWISON J. Screening for fragile X syndrome: information needs for health planners. J Med Screening 1997; 4: 60-94.
19. WÖHRLE D, KOTZOT D, HIRST M, MANCA A, KORN B, SCHIMDT A ET AL. A microdeletion of less than 250 Kpb, including the proximal part of the FMR-1 gene and the fragile-X site, in a male with the clinical phenotype of fragile X syndrome. Am J Hum Genet 1992; 51: 299-306.
20. LACASSIE Y, MORENO R, DE LA BARRA F, CUROTTO B, ALLIENDE MA, ANRÍQUEZ PE ET AL. Sindrome del X frágil: Discusión del primer caso confirmado citogenéticamente en Chile. Rev Chil Ped 1983; 54: 410-6.
21. BUTLER M, MANGRUM T, GUPTA R, SINGH D. A 15 item check-list for screening mentally retarded males for the fragile X syndrome. Clin Genet 1991; 39: 347-54.
22. JACKY P, AHUJA Y, ANYANE-YEBOA K ET AL. Guidelines for the preparation and analysis of the fragile X chromosome in lymphocytes. Am J Med Genet 1991; 38: 400-3.
23. ALLIENDE MA Y CUROTTO B. Citogenética clínica: métodos de laboratorio. Rev Chil Ped 1993; 649: 9-12.
24. MEDRANO J, AASEN E, SHARROW L. DNA extraction from nucleated red blood cells. Biotechniques 1990; 8: 43.
25. SAMBROOK J, FRITSCH E, MANIATIS T. Molecular Cloning: A Laboratory Manual. 1989. Cold Spring Harbor Laboratory Press.
26. FEINBERG A, VOGELSTEIN B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
27. SCHAFFER H, SEDEROFF R. Least squares fit of DNA fragment length to gel mobility. Anal Biochem. 1981; 115: 113-22.
28. WÖHRLE D, SALAT U, GLÄSER D, MÜCKE J, MEISEL-STOSIEK M, SCHINDLER D, ET AL. Unusual mutations in high funtioning fragile X males: apparent instability of expanded unmethylated CGG repeats. J Med Genet 1998; 35: 103-11.
29. SUTHERLAND GR. Heritable fragile sites on human chromosomes I. Factors affecting expresion in lymphocyte culture. Am J Hum Genet 1979; 31: 125-35.
30. BARNICOAT A, WANG Q, TURK J ET AL. Clinical, cytogenetic, and molecular analysis of three families with FRAXE. J Med Genet 1997; 34: 13-7.
31. KNIGHT S, HIRST M, ROCHE A, CHRISTODOULOU Z, HUSON S, WINTER R ET AL. Molecular Studies of the Fragile X Syndrome. Am J Meet Genet 1992; 43: 217-23.
32. ROCCHI M, ARCHIDIACONO N, RINALDI A, FILIPPI G, BARTOLUCCI G, FANCELLO GS ET AL. Mental retardation in heterozygotes for the fragile X mutation evidence in favor of an X inactivation dependent effect. Am J Hum Genet 1990; 46: 738-43.
33. KIRCHGESSNER W, WARREN ST AND WIELAND HF. X inactivation in the FMR-1 fragile X mental retardation gene. J Med Genet 1995; 32: 925-9.
34. WILLEMSEN R, SMITS A, MOHKAMSING S, VAN BEERENDONK H, DE HAAN A, DE VRIES B ET AL. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet 1997; 99: 3: 308-11.
35. CONDORELLI DF, MILANA G, DELL'ALBANI P, ROCCAZELLO AM, INSIKFLLO E, PAVONE L, MOLLICA F. Routine Clinical application of the FRAXA Pfu PCR assay: limits and utility. Clin Genet 1996; 50: 366-71.
36. HADDAD L, MINGRONI-NETTO R, VIANNA-MORGANTE AM, PENA S. A PCR-based test suitable for screening for fragile X syndrome among mentally retarded males. Hum Genet 1996; 97: 808-12.
37. GERARD B, LE HEUZEY MF, BRUNIE G, LEWINE P, SAIAG MC, CACHEUX V ET AL. Systematic screening for fragile X syndrome in a cohort of 574 mentally retarded children. Ann Génét 1997; 40: 139-40.